Because MCF-7 cells overexpressing CCN1 are estradiol (E2)-independent and acquire an antiestrogen resistant phenotype [16, 18], a prevalent clinical occurrence in breast cancer progression [30–33], we next evaluated whether exacerbated FASN activity might serve as part of the molecular program by which CCN1 promotes an aggressive breast cancer phenotype. Here, CCN1 is linked to breast cancer.